2017 Articles
- 1)
- Ikezaki T, Suzuki K, Kambara K, Inomata M, Okazawa S, Kajiura S, Miwa T, Tanabe K, Kashii T. Relationship between Carnitine Pharmacokinetics and Fatigue in Patients Treated with Cisplatin-Containing Chemotherapy. Oncol Res Treat. 2017 Feb;40(1-2):42-45.
- 2)
- Fujinami H，Kajiura S，Nishikawa J，Ando T，Sugiyama T. The influence of duodenally-delivered Shakuyakukanzoto (Shao Yao Gan Cao Tang) on duodenal peristalsis during endoscopic retrograde cholangiopancreatography: a randomised controlled trial. Chin Med. 2017 Jan 9; 12: 3.
- 3)
- Mihara H，Suzuki N，Muhammad JS，Nanjo S，Ando T，Fujinami H，Kajiura S，Hosokawa A，Sugiyama T. Transient receptor potential vanilloid 4 (TRPV4) silencing in Helicobacter pylori-infected human gastric epithelium. Helicobacter. 2017 Apr; 22(2). Epub 2016 Sep 30.
- 4)
- Hosokawa A，Ando T，Ogawa K，Ueda A，Yoshita H，Mihara H，Fujinami H，Kajiura S，Yabushita K，Horikawa N，Kobayashi Y，Yoshioka A，Origasa H，Sugiyama T. Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer. Am J Clin Oncol. 2017 Sep 19.[Epub ahead of print]
- 5)
- Inomata M, Tanaka H, Tokui K, Taka C, Okazawa S, Kambara K, Imanishi S, Yamada T, Miwa T, Hayashi R, Tobe K. Clinical course after initiation of nivolumab therapy in patients with EGFR-mutated Non-small cell lung cancer with or without Pd-L1 expression. Oncology and Therapy. 2017 Oct 20;5(2):181-185.
- 6)
- Taka C, Hayashi R, Shimokawa K, Tokui K, Okazawa S, Kambara K, Inomata M, Yamada T, Matsui S, Tobe K. SIRT1 and FOXO1 mRNA expression in PBMC correlates to physical activity in COPD patients. Int J Chron Obstruct Pulmon Dis. 2017 Nov 3;12:3237-3244.
- 7)
- Inomata M,Tanaka H,Shimokawa K,Tokui K,Okazawa S,Taka C,Kanbara K,Imanishi S,Yamada T,Miwa T,Hayashi R,Matsui S,Kashii T,Honma T,Nomura K,Doki Y,Tobe K,Retrospective Observational Study to Evaluate the Clinical Course of Local or Systemic Treatment in Patients with Post-Operative Recurrence of Non-Small-Cell Lung Cancer. Cancer and Chemotherapy 2017 Sep；44(9)：767-770．
